| 期刊論文| 1. | Azzaro, A. J.、Vandenberg, C. M.、Blob, L. F.、Kemper, E. M.、Sharoky, M.、Oren, D. A.(2006)。Tyramine pressor sensitivity during treatment with the transdermal system 6 mg/24 h in healthy subjects。Journal of Clinical Pharmacology，46，933-944。   | | 2. | Cody, J. T.(2002)。Precursor medicationsasasource of methamphetamine and/ or amphetaminepositive drug testing results。Journal of Occupational and Envionmental Medicine，44(5)，435-450。 | | 3. | Fernandez, H. H.、Chen, J. J.(2007)。Monoamine oxidase-B inhibition in the treatment of Parkinson’s disease。Pharmacotherapy，27，174-185。 | | 4. | Hasegawa, M.、Matsubara, K.、Fukushima, S.、Maseda, C.、Uezono, T.、Kimura, K.(1999)。Stereoselective analyses of selegiline metabolites: Possible urinary markers for selegiline therapy。Forensic Science International，101，95-106。 | | 5. | Nevescanin, M.、Stevic, S. B.、Petrovic, S.、Vajs, V.(2008)。Analysis of amphetamines illegally produced in Serbia。Journal of Serbian Chemical Society，73，691-701。 | | 6. | Nishida, K.、Itoh, S.、Inoue, N.、Kudo, K.、Ikeda, N.(2006)。High-performance liquid chromatographic-mass spectrometric determination of methamphetamine and amphetamine enantiomers, desmethylselegiline and selegiline, in hair samples of long-term methamphetamine abusers or selegiline users。Journal of Analytical Toxicology，30，232-237。 | | 7. | Reynolds, G. I.、Elsworth, J. D.、Blau, K.、Sandler, M.、Lees, A. J.、Stern, G. M.(1978)。Deprenyl is metabolized to methamphetamine and amphetamine in man。British Journal of Clinical Pharmacology，6，542-544。 | | 8. | Romberg, R. W.、Needleman, S. B.、Snyder, J. J.、Greedan, A.(1995)。Methamphetamine and amphetamine derived from the metabolism of selegiline。Journal of Forensic Sciences，40，1100-1102。 | | 9. | Heinonen, E. F.、Myllyhi, V.、Sotaniemi, K.、Lammintausta, R.、Salonen, J. S.、Anttila, M.(1989)。Pharmacokinetics and metabolism of selegiline。Acta Neurol Scand，126，93-99。 | | 10. | Karoum, F.、Chuang, L. W.、Eisler, T.、Calne, D. B.、Liebowitz, M. R.、Quitkin, F. M.(1982)。Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl’s therapeutic benefit: A biochemical assessment。Neurology，32(5)，503-509。 | | 11. | Kim, E. M.、Chung, H. S.、Lee, K. J.(20002)。Determination of enantiomeric metabolites of l-deprenyl, d-methamphetamine, and racemic methamphetamine in urine by capillary electrophoresis: Comparison of deprenyl use and methamphetamine use。Journal of Analytical Toxicology，24，238-244。 | | 12. | Kraemer, T.、Maurer, H. H.(2002)。Toxicokinetics of amphetamines: Metabolism and toxicokinetic data of designerdrugs, amphetamine, methamphetamine, and their N-alkylderivatives。Therapeutic Drug Monitoring，24(2)，277-289。 | | 13. | Musshoff, F.(2002)。Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine。Drug Metabolism Reviews，32(1)，15-44。 | 圖書| 1. | 許美智、詹貴惠(2005)。運動藥物學。高雄市：春橋田股份有限公司。 延伸查詢 | 其他| 1. | World Anti-Doping Agency.(2009)。The world anti-doping code. The 2009 prohibited list, international standard。 | |